Coldstream Capital Management Inc Immunovant, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Immunovant, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 33 shares of IMVT stock, worth $907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33Holding current value
$907% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMVT
# of Institutions
220Shares Held
66.8MCall Options Held
2.65MPut Options Held
768K-
Vanguard Group Inc Valley Forge, PA6.94MShares$191 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$165 Million7.27% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.89MShares$162 Million0.07% of portfolio
-
Black Rock Inc. New York, NY4.92MShares$135 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.87MShares$106 Million1.5% of portfolio
About Immunovant, Inc.
- Ticker IMVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 129,077,000
- Market Cap $3.55B
- Description
- Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...